Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0854720070270040257
Korean Journal of Asthma, Allergy and Clinical Immunology
2007 Volume.27 No. 4 p.257 ~ p.262
Clinical Features of Patients in Remission after House Dust Mite Allergen Immunotherapy in Adult Asthma
Hur Gyu-Young

Lee Hyun-Youn
Choi Gil-Soon
Park Han-Jung
Choi Sung-Jin
Nahm Dong-Ho
Park Hae-Sim
Abstract
Background: Although allergen specific immunotherapy has been used as the only curative treatment for allergic diseases, there have been few studies that observed the efficacy of immunotherapy in asthmatics.

Objectives : We attempted to determine clinical parameters for predicting the remission of asthma after immunotherapy with house dust mite extracts.

Methods: Fifty-six adult asthmatic patients undergoing immunotherapy with house dust mite extracts for more than 3 years were enrolled. They were classified into the remitted and unremitted group according to the results of following methacholine challenge test. Skin reactivity, immunologic findings, spirometry, and airway hyperreactivity were compared between the 2 groups.

Results: Twenty-six subjects (46.4%) were in the remitted group and 30 subjects (53.6%) were in the unremitted group. Both onset age of asthma symptoms and starting age of immunotherapy were significantly lower in the remitted group (P<0.05, for each). Baseline FEV1 levels and degree of airway hyperreactivity were significantly better in the remitted group (P<0.01 and 0.05, respectively).

Conclusion: Younger age, earlier immunotherapy as well as better lung function and airway hyperreactivity at baseline can be used to predict the remission of asthma in adults. Therefore, earlier allergen immunotherapy in younger age group might help achieve remission in adult allergic asthma.
KEYWORD
Remission, Bronchial hyperreactivity, Immunotherapy, Asthma
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø